Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
The first heart procedure of its kind | Embracing AI | Innovation in the cath lab | More from the last week
Saturday, May 20, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Cardiologists make history, removing device and implanting new valve in first heart procedure of its kind

“I was ready to make out my will, so this came along just at the right time,” the 76-year-old patient said. 

READ MORE >
Mitral Valve Surgery from the University of Washington
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists make history, removing device and implanting new valve in first heart procedure of its kind

Share on Twitter Share on Facebook Share on Linkedin
Mitral Valve Surgery from the University of Washington
“I was ready to make out my will, so this came along just at the right time,” the 76-year-old patient said. 
READ MORE >

Cardiology has embraced AI more than most other specialties

Cardiology is linked to the second largest group of FDA-cleared clinical AI algorithms, and the number is still growing. 

READ MORE >
An example of HeartFlow's new RoadMap Stenosis software that uses artificial intelligence (AI) to show areas of interest for possible stenting based on a patient's CT scan and FFR-CT. This software is still undergoing beta testing at several hospitals and will likely be rolled out commercially later in 2023.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology has embraced AI more than most other specialties

Share on Twitter Share on Facebook Share on Linkedin
An example of HeartFlow's new RoadMap Stenosis software that uses artificial intelligence (AI) to show areas of interest for possible stenting based on a patient's CT scan and FFR-CT. This software is still undergoing beta testing at several hospitals and will likely be rolled out commercially later in 2023.
Cardiology is linked to the second largest group of FDA-cleared clinical AI algorithms, and the number is still growing. 
READ MORE >

Innovation in the cath lab: Cardiologists develop, perform new interventional heart procedure

Interventional cardiologists in Detroit developed the new technique with a specific patient in mind. One specialist described it as an "exciting breakthrough."

READ MORE >
Cardiologist heart
Share on Twitter Share on Facebook Share on Linkedin

Innovation in the cath lab: Cardiologists develop, perform new interventional heart procedure

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist heart
Interventional cardiologists in Detroit developed the new technique with a specific patient in mind. One specialist described it as an "exciting breakthrough."
READ MORE >

Next-gen TAVR valve, tested on patients for very first time, linked to high success rate

A new-look TAVR valve was tested on patients for the first time, leading researchers to say its use appears to be "feasible and safe." More research, of course, is still required. 

READ MORE >
Data on a next-generation balloon-expandable transcatheter heart valve from Edwards Lifesciences, includes a new frame, new skirt and RESILIA bovine pericardial leaflets. It is currently known as the SAPIEN X4 valve.
Share on Twitter Share on Facebook Share on Linkedin

Next-gen TAVR valve, tested on patients for very first time, linked to high success rate

Share on Twitter Share on Facebook Share on Linkedin
Data on a next-generation balloon-expandable transcatheter heart valve from Edwards Lifesciences, includes a new frame, new skirt and RESILIA bovine pericardial leaflets. It is currently known as the SAPIEN X4 valve.
A new-look TAVR valve was tested on patients for the first time, leading researchers to say its use appears to be "feasible and safe." More research, of course, is still required. 
READ MORE >

Cardiologist arrested for sexual assault again, now linked to 10 alleged victims

The 35-year-old cardiologist has now been charged in a total of 10 sexual assault cases. 

READ MORE >
offender-trouble-handcuffs-police-arrest-2102488.jpg
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist arrested for sexual assault again, now linked to 10 alleged victims

Share on Twitter Share on Facebook Share on Linkedin
offender-trouble-handcuffs-police-arrest-2102488.jpg
The 35-year-old cardiologist has now been charged in a total of 10 sexual assault cases. 
READ MORE >

Marijuana use linked to much higher risk of peripheral artery disease

New research presented at SCAI Scientific Sessions 2023 suggests that marijuana users should understand the early warning signs of PAD, including feelings of pain and coldness in the leg. 

READ MORE >
The new analysis, based on data from 1.6 million patients, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. Medical marijuana
Share on Twitter Share on Facebook Share on Linkedin

Marijuana use linked to much higher risk of peripheral artery disease

Share on Twitter Share on Facebook Share on Linkedin
The new analysis, based on data from 1.6 million patients, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. Medical marijuana
New research presented at SCAI Scientific Sessions 2023 suggests that marijuana users should understand the early warning signs of PAD, including feelings of pain and coldness in the leg. 
READ MORE >

EuroPCR 2023: Late-breaking research examines the latest in TEER, TAVR and PCI outcomes

Catch up on key late-breaking research from Abbott, Edwards Lifesciences and Philips presented at the four-day meeting in Paris. 

READ MORE >
Abbott TriClip device for TEER
Share on Twitter Share on Facebook Share on Linkedin

EuroPCR 2023: Late-breaking research examines the latest in TEER, TAVR and PCI outcomes

Share on Twitter Share on Facebook Share on Linkedin
Abbott TriClip device for TEER
Catch up on key late-breaking research from Abbott, Edwards Lifesciences and Philips presented at the four-day meeting in Paris. 
READ MORE >

WHO warns against use of artificial sweeteners, highlighting CVD and diabetes risks

The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.

READ MORE >
The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.
Share on Twitter Share on Facebook Share on Linkedin

WHO warns against use of artificial sweeteners, highlighting CVD and diabetes risks

Share on Twitter Share on Facebook Share on Linkedin
The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.
The World Health Organization has published a new guideline recommending against the use of artificial sweeteners such as aspartame and sucralose to lose weight or reduce the risk of noncommunicable diseases.
READ MORE >

FDA grants fast track designation to Bayer’s new drug for preventing stroke in AFib patients

The new drug, asundexian, is currently the subject of two multicenter Phase III studies—the OCEANIC-AF trial and OCEANIC-STROKE trial—focused on its safety and efficacy.

READ MORE >
Arrow
Share on Twitter Share on Facebook Share on Linkedin

FDA grants fast track designation to Bayer’s new drug for preventing stroke in AFib patients

Share on Twitter Share on Facebook Share on Linkedin
Arrow
The new drug, asundexian, is currently the subject of two multicenter Phase III studies—the OCEANIC-AF trial and OCEANIC-STROKE trial—focused on its safety and efficacy.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup